Topics

Immunicum - Full analysis of MERECA top-line results

03:58 EDT 11 Oct 2019 | FinanzNachrichten

The last several weeks have been volatile for Immunicum and illustrate how complicated immunotherapy efficacy trials can be. On 29 August 2019, the company released top-line results from the Phase ...

Original Article: Immunicum - Full analysis of MERECA top-line results

NEXT ARTICLE

More From BioPortfolio on "Immunicum - Full analysis of MERECA top-line results"

Quick Search